- Home
- TIL vs NXC Comparison
TIL vs NXC Comparison
Compare TIL & NXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- NXC
- Stock Information
- Founded
- TIL 2018
- NXC 1992
- Country
- TIL United States
- NXC United States
- Employees
- TIL N/A
- NXC N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- NXC Investment Managers
- Sector
- TIL Health Care
- NXC Finance
- Exchange
- TIL Nasdaq
- NXC Nasdaq
- Market Cap
- TIL 230.1M
- NXC 84.3M
- IPO Year
- TIL 2021
- NXC N/A
- Fundamental
- Price
- TIL $24.49
- NXC $12.97
- Analyst Decision
- TIL Buy
- NXC
- Analyst Count
- TIL 5
- NXC 0
- Target Price
- TIL $119.00
- NXC N/A
- AVG Volume (30 Days)
- TIL 310.3K
- NXC 17.5K
- Earning Date
- TIL 08-12-2025
- NXC 01-01-0001
- Dividend Yield
- TIL N/A
- NXC 3.97%
- EPS Growth
- TIL N/A
- NXC N/A
- EPS
- TIL N/A
- NXC 0.19
- Revenue
- TIL N/A
- NXC N/A
- Revenue This Year
- TIL N/A
- NXC N/A
- Revenue Next Year
- TIL N/A
- NXC N/A
- P/E Ratio
- TIL N/A
- NXC $70.47
- Revenue Growth
- TIL N/A
- NXC N/A
- 52 Week Low
- TIL $9.70
- NXC $11.86
- 52 Week High
- TIL $92.00
- NXC $13.70
- Technical
- Relative Strength Index (RSI)
- TIL 47.69
- NXC 53.92
- Support Level
- TIL $21.80
- NXC $12.88
- Resistance Level
- TIL $26.91
- NXC $13.04
- Average True Range (ATR)
- TIL 3.52
- NXC 0.13
- MACD
- TIL -0.37
- NXC -0.00
- Stochastic Oscillator
- TIL 35.14
- NXC 49.04
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About NXC Nuveen California Select Tax-Free Income Portfolio
Nuveen CA Select Tax Free Income Port is a diversified closed-end management investment company. Its objective is to provide stable dividends exempt from both regular federal and California income taxes, consistent with the preservation of capital by investing in municipal obligations.